Back
Speaker illustration

undefined undefined undefined

Presentations

Effect of dapagliflozin in patients in Asia with heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: State-of-the art treatment of HFmrEF and HFpEF in 2023

Access
Like
Thumbnail

Echocardiographic characterization of patients with supranormal ejection fraction: pooled core laboratory analysis of the TOPCAT and PARAGON-HF trials

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Insights from recent HFpEF trials 1

Access
Like
Thumbnail

Sex differences in clinical characteristics and outcomes after acute myocardial infarction: insights from PARADISE-MI

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 7

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources